Conference Coverage

Concurrent Care Hospice: Tales from Minneapolis

Author and Disclosure Information

 

Background: Concurrent care hospice allows veterans to have both disease-modifying therapy, such as chemotherapy, and hospice care. While available nationally since the VA Comprehensive End-of-Life Care Initiative 2009-2012, it has not been implemented uniformly. The palliative care team at the Minneapolis VA began to actively promote concurrent care in July of 2018. Our team includes three physicians, one nurse practitioner, social worker, hospice nurse coordinator, palliative RN, chaplain, and oncology clinical nurse specialist. We hope to share what we have learned as an interdisciplinary team and how we will continue to promote concurrent care going forward.

Results: To date, 38 patients have enrolled in concurrent care hospice through 13 hospice agencies. By chart review, we found that most patients have died (22/38 enrolled). The average length of time to death from the initial enrollment with concurrent care hospice was just over 60 days, while the average for usual hospice cancer patients is about 50 days. Two patients enrolled longer than 6 months are still living. Most patients died at home or a nursing home (19/22) while 2 died in our CLC and 1 at our inpatient hospital.

Discussion: We have identified several barriers to enrollment. Hospices have expressed concern that concurrent care is not consistent with the philosophy of hospice care and may result in withheld Medicare payments. Our hospice coordinator has invested a significant amount of time educating hospices and establishing relationships. Several agencies have declined to enroll these patients and for agencies accepting patients, the review process is more rigorous and time-consuming. Internally, our biggest partners are in oncology. We had the opportunity to present our initial data and rationale for concurrent care at a monthly oncology staff meeting. While many staff saw the benefit of adding hospice support, several physicians expressed concern that hospice patients will not receive proper medical attention for chemotherapy- related side effects. We discussed communication as the best tool to help veterans and hospice agencies understand the needs of concurrent care patients. Going forward, we hope that concurrent care becomes a normal, utilized component of best practice for our veterans.

Recommended Reading

Mohs Micrographic Surgery in the VHA (FULL)
AVAHO
A National WestlawNext Database Analysis of Malpractice Litigation in Radiation Oncology (FULL)
AVAHO
Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man (FULL)
AVAHO
Advance care planning codes not being used
AVAHO
Impact of Integrated Oncology- Palliative Care Outpatient Model on Trends of Palliative Care and Hospice Care Referrals From Oncology
AVAHO
The Impact of Registered Dietitian Staffing and Nutrition Practices in High-Risk Cancer Patients Across the Veterans Health Administration
AVAHO
Integrated Outpatient Palliative Care for Patients with Advanced Cancer: A Systematic Review and Meta-Analysis
AVAHO
The Impact of End of Life Chemotherapy on Quality of Life and Life Expectancy
AVAHO
Integrating Palliative Care into Inpatient Oncology Service Via “Lightning Rounds”: A Pilot Study
AVAHO
Expanding Access to Care with Palliative Video Telehealth
AVAHO